Structure Therapeutics Ownership | Who Owns Structure Therapeutics?
Structure Therapeutics Ownership Summary
Structure Therapeutics is owned by 14.46% institutional investors, 2.86% insiders, and 82.68% retail investors. Wellington management group llp is the largest institutional shareholder, holding 29.66% of GPCR shares.
GPCR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Structure Therapeutics | 14.46% | 2.86% | 82.68% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Wellington management group llp | 5.69M | 29.66% | $159.30M |
| Fmr | 5.25M | 27.37% | $147.01M |
| Avoro capital advisors | 5.16M | 26.88% | $144.36M |
| Deep track capital, lp | 4.22M | 21.98% | $118.04M |
| Bvf inc/il | 3.20M | 16.70% | $89.71M |
| Baker bros. advisors lp | 1.56M | 8.11% | $43.57M |
| Casdin capital | 1.55M | 8.11% | $43.54M |
| Ra capital management | 1.52M | 7.91% | $42.49M |
| Ameriprise financial | 1.22M | 6.38% | $34.28B |
| Orbimed advisors | 1.14M | 5.94% | $31.90M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sectoral asset management | 221.87K | 3.83% | $6.21M |
| Bvf inc/il | 3.20M | 3.64% | $89.71M |
| Casdin capital | 1.55M | 3.63% | $43.54M |
| Catalio capital management, lp | 651.81K | 3.37% | $18.25M |
| Deep track capital, lp | 4.22M | 3.29% | $118.04M |
| Monashee investment management | 200.00K | 2.79% | $5.60M |
| Logos global management lp | 850.00K | 2.13% | $23.80M |
| Avoro capital advisors | 5.16M | 1.87% | $144.36M |
| Birchview capital, lp | 78.00K | 1.65% | $2.18M |
| Highvista strategies | 236.24K | 1.62% | $6.61M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | 5.16M | 1.87% | 5.16M |
| Bvf inc/il | 3.20M | 3.64% | 1.43M |
| Siren | 1.03M | 1.12% | 1.03M |
| Paradigm biocapital advisors lp | 372.87K | 0.30% | 372.87K |
| Fmr | 5.25M | 0.01% | 335.40K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital research global investors | - | - | -2.16M |
| Capital investors | - | - | -1.62M |
| Vestal point capital, lp | - | - | -1.20M |
| Wellington management group llp | 5.69M | 0.03% | -1.19M |
| Fil | - | - | -1.15M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Avoro capital advisors | 5.16M | 1.87% | 5.16M | $144.36M |
| Siren | 1.03M | 1.12% | 1.03M | $28.75M |
| Paradigm biocapital advisors lp | 372.87K | 0.30% | 372.87K | $10.44M |
| Alyeska investment group | 244.85K | 0.02% | 244.85K | $6.86M |
| Two sigma investments, lp | 182.91K | 0.01% | 182.91K | $5.12M |
Sold Out
| Holder | Change |
|---|---|
| Mai capital management | -10.00 |
| Us bancorp \de\ | -13.00 |
| Federation des caisses desjardins du quebec | -20.00 |
| Skopos labs | -32.00 |
| Mather group, llc. | -35.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 45 | -75.94% | 2,773,848 | -94.92% | 14 | 0.16% | 18 | -82.86% | 15 | -63.41% |
| Jun 30, 2025 | 186 | 11.38% | 54,608,579 | -2.37% | 94 | 99.54% | 103 | 47.14% | 42 | -16.00% |
| Mar 31, 2025 | 32 | -82.32% | 17,076,259 | -71.82% | 2 | 0.20% | 11 | -88.17% | 8 | -82.98% |
| Dec 31, 2024 | 184 | 4.55% | 60,629,867 | -1.30% | 38 | 2.54% | 94 | -2.08% | 49 | 28.95% |
| Sep 30, 2024 | 176 | -9.28% | 61,427,326 | 3.62% | 38 | 21.50% | 96 | -22.58% | 38 | -2.56% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 08, 2025 | FMR LLC | See Remark 1 | Sell | - |
| Dec 08, 2025 | FMR LLC | See Remark 1 | Sell | - |
| Dec 08, 2025 | FMR LLC | See Remark 1 | Sell | - |
| Dec 08, 2025 | FMR LLC | See Remark 1 | Sell | - |
| Dec 08, 2025 | FMR LLC | See Remark 1 | Sell | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 10 |
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 1 |
| 2024 Q4 | - | - |
GPCR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools